Journal of Applied Physiology Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 87: 1813-1822, 1999;
8750-7587/99 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gastaldelli, A.
Right arrow Articles by Wolfe, R. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gastaldelli, A.
Right arrow Articles by Wolfe, R. R.
Vol. 87, Issue 5, 1813-1822, November 1999

Assessment of methods for improving tracer estimation of non-steady-state rate of appearance

A. Gastaldelli1,2, A. R. Coggan1, and R. R. Wolfe1

1 Metabolism Unit, Shriners Burns Institute, and University of Texas Medical Branch, Galveston, Texas 77550-2725; and 2 Institute of Clinical Physiology, National Research Council, Pisa 56100, Italy


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
APPENDIX

The most common approach for estimating substrate rate of appearance (Ra) is use of the single-pool model first proposed by R. W. Steele, J. S. Wall, R. C. DeBodo, and N. Altszuler. (Am. J. Physiol. 187: 15-24, 1956). To overcome the model error during highly non-steady-state conditions due to the assumption of a constant volume of distribution (V), two strategies have been proposed: 1) use of a variable tracer infusion rate to minimize tracer-to-tracee ratio (TTR) variations (fixed-volume approach) or 2) use of two tracers of the same substrate with one infused at a constant rate and the other at a variable rate (variable-volume approach or approach of T. Issekutz, R. Issekutz, and D. Elahi. Can. J. Physiol. Pharmacol. 52: 215-224, 1974). The goal of this study was to compare the results of these two strategies for the analysis of the kinetics of glycerol and glucose under the non-steady-state condition created by a constant infusion of epinephrine (50 ng · kg-1 · min-1) with the traditional approach of Steele et al., which uses a constant infusion and fixed volume. The results showed that for glucose and glycerol the estimates of Ra obtained with the constant and the variable tracer infusion rate and the equation of Steele et al. were comparable. The variable tracer infusion approach was less sensitive to the choice of V in estimating Ra for glycerol and glucose, although the advantage of changing the tracer infusion rate was greater for glucose than for glycerol. The model of Issekutz et al. showed instability when the ratio TTR1/TTR2 approaches a constant value, and the model is more sensitive to measurement error than the constant-volume model for glucose and glycerol. We conclude that the one-tracer constant-infusion technique is sufficient in most cases for glycerol, whereas the one-tracer variable-infusion technique is preferable for glucose. Reasonable values for glucose Ra can be obtained with the constant-infusion technique if V = 145 ml/kg.

stable isotopes; epinephrine; glycerol; glucose


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
APPENDIX

IN VIVO MEASUREMENT of the rate of appearance (Ra) of substrates in nonsteady state is of importance in physiological investigation. Many studies have been performed to validate methods for estimating glucose Ra (1-3, 6-9, 11, 12, 15). However, this is not the case for other substrates, such as glycerol. The most common approach used to calculate Ra is the single-pool model proposed by Steele et al. in 1956 (16). It consists of calculating substrate Ra by estimating the model parameters from measurements of concentration [C(t)] and tracer-to-tracee ratio (TTR) obtained after a constant tracer infusion [i(t)]
R<SUB>a</SUB>(<IT>t</IT>) = <FR><NU>i(<IT>t</IT>) − V ⋅ C(<IT>t</IT>) ⋅ <FR><NU>dTTR(<IT>t</IT>)</NU><DE>d<IT>t</IT></DE></FR></NU><DE>TTR(<IT>t</IT>)</DE></FR> (1)
where V is the volume of distribution. Since then, the model of Steele et al. has been widely adopted. During the 1980s, however, many studies revealed the inadequacy of this model for glucose during highly non-steady-state conditions (1, 3, 6-9, 12). The model error of the equation of Steele et al. is mainly associated with the choice of V, which is experiment dependent. V is usually calculated as an empirical fraction (p) of the total pool size to account for imprecision due to the fact that samples are obtained from the circulation, which equilibrates more rapidly than the other pools. The model error can theoretically be minimized by 1) limiting the variations in enrichment (3), expressed as TTR or specific activity for the radioactive case, 2) estimating the variations in the pool size by use of a second tracer [approach of Issekutz et al. (9)], or 3) using a multiple-pool model.

The first approach consists of infusing the tracer at a rate that matches the changes in endogenous Ra (and therefore requires some a priori knowledge of the expected Ra variations). In this way, TTR is constant and Ra is calculated by the following steady-state equation: Ra(t) congruent  i(t)/TTR(t).

The second approach can be accomplished by infusing two tracers at different rates. The time-varying volume is the volume that allows the correct calculation of the Ra in plasma of the first tracer from the Ra of the second tracer plus the plasma concentration of the two tracers. It has recently been shown that the estimated volume is experiment dependent and, therefore, does not reflect true changes in V (2). Nevertheless, this approach should give the best estimate of Ra by using the single-pool model, since it considers the information obtained by the contemporary infusion of two tracers and has the advantage of not requiring a preliminary study to determine the pattern of tracer infusion that matches changes in endogenous Ra. On the other hand, it is more expensive and time consuming, since it requires the contemporary infusion of two tracers of the same substrate. From a mathematical point of view (2), 1) this method is very sensitive to measurement error and 2) this approach gives the exact estimate of endogenous Ra only if one of the two tracers is infused at a rate that matches perfectly changes in endogenous Ra (i.e., TTR is kept constant). If this is the case, however, we do not need the second tracer: if TTR is constant, the equation of Steele et al. gives the exact estimate of Ra, since it is not dependent on the choice of V.

The third approach, the multiple-pool model, requires a more complicated mathematical analysis and is not treated here.

The goal of this study was to test the ability of the fixed-volume [i.e., traditional model of Steele et al. (12, 16)] and the variable-volume single-pool model [i.e., the model of Issekutz et al. (9)] to estimate Ra under non-steady-state conditions. In particular, we were interested in studying the kinetics of glycerol when lipolysis is stimulated, since glycerol has not been widely investigated from a modeling point of view. Many studies on lipolysis have used the traditional model of Steele et al. (16) to estimate glycerol Ra in non-steady-state conditions. The crucial point is the choice of V, since the appropriate value is not clear from the literature. Moreover, it is generally difficult to design a study that minimizes variations in glycerol enrichment, since its kinetics are not as tightly regulated as those of glucose, and the inter- and intrasubject variability is very high. Therefore, we wanted to know the extent to which limiting variations in enrichment is important in the estimation of glycerol kinetics and whether the infusion of two tracers allowed us to obtain a better estimate of Ra. Using the same approach, we also studied glucose kinetics so we could compare the results of the two models for two different substrates.


    METHODS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
APPENDIX

Subjects

Five healthy volunteers (2 women and 3 men) aged 27-33 yr were studied. A medical history of the subjects was obtained; they were given a routine physical examination and also routine blood and urine screening tests, as well as an electrocardiogram. The nature, purpose, and possible risk of the experimental procedures were explained to each subject before his/her written consent to participate was obtained. The experimental protocol was approved by the Institutional Review Board of the University of Texas Medical Branch.

The subjects reported to the General Clinical Research Center of the University of Texas Medical Branch at Galveston on the day before the study to eat a standard high-carbohydrate meal at about 6 PM, and then they went home, where they were asked to drink two cans of Ensure Plus (Ross Laboratories, Columbus, OH) at about 10 PM to increase their glycogen storage. On the next morning at about 7 AM they were admitted to the General Clinical Research Center for the performance of the experiment.

Experimental Protocol

Indwelling catheters were placed into the antecubital vein of one arm for tracer and epinephrine infusion and into a contralateral dorsal hand vein for arterialized venous sampling by the heated hand technique. A blood sample was drawn before the tracer infusion was started to determine background enrichment. The glucose and glycerol tracers were infused following the primed constant-infusion approach (starting 120 and 90 min before epinephrine infusion for glucose and glycerol, respectively) to reach isotopic steady state. Then, at time 0, epinephrine was infused (50 ng · kg-1 · min-1) for 1 h. Deuterated tracers were infused at constant rate ([6,6-2H]glucose: 0.61 µmol · kg-1 · min-1, priming dose 48.8 µmol/kg; [1,1,2,3,3-2H]glycerol: 0.21 µmol · kg-1 · min-1, priming dose 3 µmol/kg). A carbon-labeled tracer of each substrate, [1-13C]glucose and [2-13C]glycerol, was infused during the basal period at constant rate ([1-13C]glucose: 0.22 µmol · kg-1 · min-1, priming dose 17.6 µmol/kg; [2-13C]glycerol: 0.1 µmol · kg-1 · min-1, priming dose 1.5 µmol/kg) and during epinephrine infusion at a variable rate (Fig. 1, Table 1) necessary to maintain isotopic steady state. The changes in 13C tracer infusion rates were based on the changes in glucose and glycerol Ra observed in pilot experiments of identical design.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 1.   Glucose (top) and glycerol (bottom) tracer infusion rates. Glucose infusion started 120 min before epinephrine infusion; glycerol infusion started 90 min before epinephrine infusion.


                              
View this table:
[in this window]
[in a new window]
 
Table 1.   Protocol for changing tracer infusion during epinephrine infusion

Blood samples (7 ml) were collected before the tracer infusion was started at -10, -5, and 0 min (where 0 min indicates the moment just before the start of the epinephrine infusion) and at 2, 4, 6, 8, 10, 12, 15, 20, 25, 30, 35, 40, 50, and 60 min.

Sample Analysis

Plasma glucose concentration was measured using a glucose/lactate analyzer (model YSI 2300, Yellow Springs Instruments, Yellow Springs, OH). The enrichments of [6,6-2H]- glucose and [1-13C]glucose were determined as TTR (4, 5, 14), as previously described (17). Briefly, isotopic enrichment was determined on the pentaacetate derivative by gas chromatography-mass spectrometry (model 5985, Hewlett-Packard, Palo Alto, CA) with use of electronic impact ionization by selectively monitoring ions of rounded molecular weight (rmw) 242, 243, and 244 for [6,6-2H]glucose and 331 and 332 for [1-13C]glucose. Correction was made for the contribution of singly labeled molecules (rmw 243) to the apparent enrichment of rmw 244 (17).

Glycerol concentrations were measured by enzymatic colorimetric assay (model RA-500, Technicon, Tarrytown, NY). Isotopic enrichment of [1,1,2,3,3-2H]glycerol and [2-13C]glycerol was determined on the Tris-trimethylsilyl derivative by gas chromatography-mass spectrometry, as previously described (17). Ions of rmw 205, 206, 207, and 208 were monitored. [2-13C]glycerol was determined by monitoring the ratio 206/205. [1,1,2,3,3-2H]glycerol enrichment was determined by monitoring the ratio 208/205. Correction was made for the contribution of rmw 206 and 207 to the apparent enrichment of the ions of rmw 208 (17).

Calculations

Before modeling analysis, enrichment and concentration data were filtered by a spline-fitting approach with use of a second-order polynomial. TTR derivative was calculated analytically.

Approach 1: one-tracer infusion. Glucose and glycerol Ra were calculated using the equation of Steele et al. (12, 16) as modified for use with stable isotopes (13)
R<SUB>a</SUB>(<IT>t</IT>) = <FR><NU>i(<IT>t</IT>) − V ⋅ C(<IT>t</IT>) ⋅ <FR><NU>dTTR(<IT>t</IT>)</NU><DE>d<IT>t</IT></DE></FR></NU><DE>TTR(<IT>t</IT>)</DE></FR>
where TTR(t) is the enrichment at time t calculated according to Rosenblatt et al. (14), i(t) is the tracer infusion rate (constant or time variable to match TTR), and C(t) is the endogenous concentration calculated from the measured concentration [Cm(t)] as
C(<IT>t</IT>) = <FR><NU>C<SUB>m</SUB>(<IT>t</IT>)</NU><DE>1 + <LIM><OP>∑</OP><LL><IT>i</IT></LL></LIM> TTR<SUB><IT>i</IT></SUB>(<IT>t</IT>)</DE></FR> (2)
When stable isotope tracers are infused, the measured substrate concentration is the sum of the concentration of the endogenous substrate and the contribution of all the tracers injected, since their mass is not negligible
C<SUB>m</SUB>(<IT>t</IT>) = C(<IT>t</IT>) + C<SUB>[<SUP>2</SUP>H]</SUB>(<IT>t</IT>) + C<SUB>[<SUP>13</SUP>C]</SUB>(<IT>t</IT>)  (3)

= C(<IT>t</IT>) ⋅ [1 + TTR<SUB>[<SUP>2</SUP>H]</SUB>(<IT>t</IT>) + TTR<SUB>[<SUP>13</SUP>C]</SUB>(<IT>t</IT>)]
The volume of distribution V was assumed to be constant and equal to 145 ml/kg (P = 0.63 of total V) for glucose and 230 ml/kg (extracellular V) for glycerol. Bounds for the Ra estimate were calculated with the assumption that glucose apparent V varies between 40 ml/kg (plasma pool size) and 230 ml/kg (extracellular pool size), and glycerol apparent V was assumed to vary between 40 ml/kg (plasma pool size) and 570 ml/kg (total body water).

Approach 2: two-tracer infusion. Ra was also calculated according to the approach of Issekutz et al. (9), which involves estimating the time-varying V [V(t)] by using the information from the two tracers, [6,6-2H]glucose or [1,1,2,3,3-2H]glycerol (tracer 1), infused at constant rate (i1), and [1-13C]glucose or [2-13C]glycerol (tracer 2), infused at a variable rate [i2(t)] during epinephrine infusion. Ra was then estimated from TTR of tracer 1 (infused at rate i1) or tracer 2 [infused at rate i2(t)]
R<SUB>a</SUB>(<IT>t</IT>) = <FR><NU>i<SUB>1</SUB> − V(<IT>t</IT>) ⋅ C(<IT>t</IT>) ⋅ <FR><NU>dTTR<SUB>1</SUB>(<IT>t</IT>)</NU><DE>d<IT>t</IT></DE></FR></NU><DE>TTR<SUB>1</SUB>(<IT>t</IT>)</DE></FR> (4)
where
V(<IT>t</IT>) = <FR><NU>i<SUB>1</SUB> − i<SUB>2</SUB>(<IT>t</IT>) ⋅ <IT>y</IT>(<IT>t</IT>)</NU><DE>C(<IT>t</IT>) ⋅ <FR><NU>d<IT>y</IT>(<IT>t</IT>)</NU><DE>d<IT>t</IT></DE></FR> ⋅ TTR<SUB>2</SUB>(<IT>t</IT>)</DE></FR> (5)
and
<IT>y</IT>(<IT>t</IT>) = <FR><NU>TTR<SUB>1</SUB>(<IT>t</IT>)</NU><DE>TTR<SUB>2</SUB>(<IT>t</IT>)</DE></FR> (6)
In the formula to calculate Ra, the concentration is that of the endogenous substrate [C(t)], which can be estimated from the measured concentration [Cm(t)] by correcting for the contribution of tracers 1 and 2, as described previously. However, by substituting Eq. 5 in Eq. 4, C(t) is cancelled out and is not necessary to calculate Ra (see Eq. A7).

Statistical Analysis

Values are means ± SE. Variability of a measure x was expressed as variation from the expected value (xm)
ϕ = <FR><NU><IT>x</IT> − <IT>x</IT><SUB>m</SUB></NU><DE><IT>x</IT><SUB>m</SUB></DE></FR> ⋅ 100% (7)


    RESULTS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
APPENDIX

Concentrations and Enrichments

Plasma glucose (4.9 ± 0.17 mM basal) progressively increased during epinephrine infusion, reaching values 55% above baseline after 60 min (7.67 ± 0.31 mM at 50 min; Fig. 2, top). Plasma glycerol concentration (0.032 ± 0.003 mM basal) also rose progressively to five times the basal value (0.156 ± 0.016 mM at 25 min) and then started to decrease to reach a value equivalent to three times the basal measurement (0.091 ± 0.014 mM at 60 min; Fig. 2, bottom).


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 2.   Left, top: plasma glucose concentration (open circle ), [6,6-2H]glucose tracer-to-tracee ratio (TTR, ), and [1-13C]glucose (tracer 2) TTR (); bottom: plasma glucose concentration (open circle ), [1,1,2,3,3-2H]glycerol TTR (), and [2-13C]glycerol TTR (). Glucose and glycerol data were normalized to basal value. Values are means ± SE. Right: pattern of TTR derivatives calculated analytically by spline-fitting program from glucose (top) and glycerol (bottom) enrichments.

[1-13C]glucose (tracer 2) enrichment variations from the basal value were ~5%, whereas [6,6-2H]glucose (tracer 1) enrichment decreased on average by 25% of the basal value (Fig. 2; TTRbasal1 = 0.062 ± 0.002, TTRbasal2 = 0.025 ± 0.002). On average, [2-13C]glycerol (tracer 2) TTR first decreased and then increased, varying 15% around the basal value. [1,1,2,3,3-2H]glycerol (tracer 1) TTR decreased instead 75% below the basal value (TTRbasal1 = 0.134 ± 0.026, TTRbasal2 = 0.065 ± 0.012). The percent changes from basal of concentration and TTR are shown in Fig. 2.

Calculation of Ra

Approach 1: one-tracer infusion. Glucose (V = 145 ml/kg) Ra was estimated, with both tracers, to increase up to 2.5 times the basal value in the first 5 min (Fig. 3). However, Ra estimated from tracer 1 varied up to 43% and up to 17% when tracer 2 was used (variability calculated according to Eq. 7, where xm is the Ra obtained with V = 145 ml/kg and when x is Ra obtained with V = 40 or 230 ml/kg; Fig. 3).


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 3.   A: average glucose rate of appearance (Ra) estimated using a fixed pool volume [volume of distribution (V)] of 145 ml/kg with tracer 1 and tracer 2. B: average glucose Ra estimated from [6,6-2H]glucose TTR (tracer 1) with a fixed pool volume of 40, 145, and 230 ml/kg. C: average glucose Ra estimated from [1-13C]glucose TTR (tracer 2) with a fixed pool volume of 40, 145, and 230 ml/kg. Ra estimates were normalized to basal value. Values are means ± SE.

Glycerol (V = 230 ml/kg) tracers gave a similar estimate of the Ra pattern (Fig. 4). Ra showed an increase up to five times the basal value, reaching a peak 20 min after the epinephrine infusion. Glycerol Ra showed a variability up to 20% when tracer 2 data were used and up to 40% when Ra was calculated from tracer 1 (Fig. 4).


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 4.   A: average glycerol Ra estimated using a fixed pool volume of 230 ml/kg with tracer 1 and tracer 2. B: average glucose Ra estimated from [1,1,2,3,3-2H]glycerol TTR (tracer 1) with a fixed pool volume of 40, 230, and 570 ml/kg. C: average glycerol Ra estimated from [2-13C]glycerol TTR (tracer 2) with a fixed pool volume of 40, 230, and 570 ml/kg. Ra estimates were normalized to basal value. Values are means ± SE.

Approach 2: two-tracer infusion. The contemporary infusion of two tracers of glucose and glycerol allowed us to use the variable-volume single-pool model [approach of Issekutz et al. (9)] to estimate Ra. Figures 5 and 6 show the glucose and glycerol Ra obtained from tracer 2 data with use of the equation of Steele et al. (16) compared with the Ra values obtained using the approach of Issekutz et al. (9) for each subject. On average, the Ra estimates were almost superimposable (data not shown). However, for a given subject, Ra calculated using the approach of Issekutz et al. was more variable than the estimates obtained using the traditional single-pool model, showing the presence of singularities when the ratio TTR1/TTR2 approached a constant value (Figs. 5 and 6).


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 5.   Glucose Ra estimated by [1-13C]glucose TTR (V = 145 ml/kg, solid line) and by approach of Issekutz et al. (Ref. 9; dashed line) for subjects 1 (A), 2 (B), 3 (C), 4 (D), and 5 (E). Ra estimates were normalized to basal value.



View larger version (16K):
[in this window]
[in a new window]
 
Fig. 6.   Glycerol Ra estimated from [2-13C]glycerol TTR (V = 230 ml/kg, solid line) and by approach of Issekutz et al. (Ref. 9; dashed line) for subjects 1 (A), 2 (B), 3 (C), 4 (D), and 5 (E). Ra estimates were normalized to basal value.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
APPENDIX

The goal of this study was to compare under non-steady-state conditions Ra estimates obtained after the infusion of a single tracer [i.e., with the model of Steele et al. (12, 16)] with estimates obtained after infusion of two tracers [i.e., with the model of Issekutz et al. (9)]. In particular, we wanted to know how important in the estimation of glycerol kinetics it is to limit the variations in enrichment and whether the infusion of two tracers allows us to obtain a better estimate of Ra. We compared the results with those obtained using the same approaches to quantify the better-defined glucose system. The non-steady-state condition was created by a constant infusion of epinephrine (50 ng · kg-1 · min-1). Epinephrine was chosen, since it creates rapid non-steady-state changes in glucose and glycerol that peak and subside within 1 h (15). The high rate of epinephrine infusion was necessary to stimulate glucose production. For each substrate we infused two tracers: tracer 1 (a 2H-labeled tracer) at constant rate and tracer 2 (a 13C-labeled tracer) at a rate that was designed to match the expected changes in endogenous Ra. These tracers have been shown to give the same estimates of Ra when infused simultaneously at the same rate (10, 17), and simultaneous use of the two tracers enabled us to eliminate intrasubject variability in the comparison of the constant and the variable infusion rate techniques.

Many studies have shown that the reliability of the traditional model of Steele et al. (16) for the estimation of glucose Ra in the nonsteady state is dependent on the choice of the effective V and, thus, is inversely related to the variation of the TTR (1-3, 6-9, 11, 12, 15). In other words, the higher the derivative of TTR, the higher the variability of the Ra estimate will be. The problem can be overcome 1) by minimizing the variation in TTR (3, 6, 7) or 2) by infusing two tracers of the same substrate, one at a constant rate and the other at a variable rate, with use of the information of both tracers to estimate not only the Ra but also the variations of the apparent V, as proposed by Issekutz et al. (9). The first approach is simple but requires a priori knowledge of the pattern of the Ra response to the stimulus; the latter can often be estimated for glucose, but this is more difficult for substrates such as glycerol because of inter- and intrasubject variability in response. The second approach requires the infusion of a second tracer to estimate the variations in V. This approach was designed to give a better estimate of Ra at the beginning of the stimulus, where the fixed-volume model may be adequate to describe the substrate kinetics. However, Caumo et al. (2) recently showed that, theoretically, the variable-volume model gives the exact estimate of Ra only if one of the two tracers is infused at a rate that exactly matches changes in endogenous Ra. If this is the case, however, there is no advantage in infusing a second tracer at constant rate, because if TTR is constant, we obtain an exact estimate of Ra, also with use of the traditional equation of Steele et al. (16). Moreover, the calculation of the variable volume is potentially dependent on the measurement error (2), and the model of Issekutz et al. (9) shows a singularity when the ratio TTR1/TTR2 approaches a constant value (see APPENDIX).

Approach 1: One-Tracer Infusion

The model of Steele et al., (16) given its generality, can be used to study a large number of substrates. We studied the kinetics of glucose and glycerol in response to epinephrine infusion, since this hormone stimulates glucose production and lipolysis. The problems with this model for assessment of rapid changes in glucose Ra have been well documented. However, less information is available regarding assessment of glycerol Ra in the nonsteady state. Moreover, the optimal value of V for the calculation of glycerol Ra by use of the equation of Steele et al. in not known. We recently proposed (13) a value of 230 ml/kg, which corresponds to the volume of the extracellular fluid, but in theory the effective V for glycerol could vary between 40 (plasma volume) and 570 ml/kg (total body water). For glucose, reasonable values for V could range from 40 (plasma volume) to 230 ml/kg (extracellular fluid volume). We previously used 100 ml/kg during high-intensity exercise (13), since in this case glucose turnover is increased and the apparent V is presumably smaller. In the present study we used 145 ml/kg, which corresponds to p = 0.63 of the total V (i.e., 230 ml/kg). We compared Ra estimates obtained using different values of V for both substrates (Figs. 3 and 4). The results for glucose showed that, as expected (3), the choice of V is less important if the TTR variations are minimized. Glucose Ra estimated from tracer 2 with use of the fixed-V single-pool model was comparable to that estimated from tracer 1 (Fig. 3). However, the variability of Ra estimated from tracer 1 with different values for V was higher than the variability obtained from tracer 2 data (43 vs. 17%; Fig. 3). During epinephrine infusion, gluconeogenesis is highly stimulated, and this can cause some problem in the estimation of TTR because of 13C label recycling. However, this does not seem to be a problem in this study, given that Ra estimates were comparable.

Glycerol Ra, estimated from tracer 2 with a fixed volume of 230 ml/kg, was similar to that obtained from tracer 1 infused at a constant rate (Fig. 4). Therefore, we conclude that the glycerol fixed-volume single-pool model is able to describe plasma glycerol data even when the enrichment drops by 75% in 30 min (Fig. 2). This is probably because of the high turnover rate of the glycerol pool compared with glucose. The high turnover rate of the glycerol pool results in an equilibration being achieved throughout the glycerol pool much more rapidly than is the case with glucose. This is also reflected by the fact that a much smaller priming dose is needed for glycerol than for glucose. Nonetheless, when glycerol TTR changes were limited by the variable-infusion technique, the variability in Ra estimates was lower (20 vs. 40%; Fig. 4). Thus, whereas it is possible to obtain a more precise estimate of glycerol Ra by limiting variations in glycerol enrichment, a constant tracer infusion approach does not affect the accuracy of the Ra estimate. This is an important result, since glycerol kinetics are not easily predictable, and therefore it is difficult to determine a priori the rate of tracer infusion needed to keep the enrichment constant.

Approach 2: Two-Tracer Infusion

The second part of this study involved estimating glycerol and glucose Ra by use of the variable-volume single-pool model first proposed by Issekutz et al. (9). The approach of Issekutz et al. applied to the single-pool model was believed to give the best estimate of Ra, since it avoids the problem of choosing a constant value for V or trying to infuse the tracer at a rate that matches endogenous Ra. In this study the Ra estimated using this approach was generally the same as that obtained using the traditional equation of Steele et al. (16) (Fig. 5), but the model artifact predicted a sudden change. This can be explained by the fact that the approach of Issekutz et al. (9) is accurate when the two enrichments are varying independently but presents a singularity when the ratio TTR1/TTR2 approaches a constant value: in this case, the denominator of V(t) approaches zero, which is reflected by a sudden change in Ra (see APPENDIX). Moreover, the estimated V does not have a physiological meaning, and its value strictly depends on the protocols of infusion of the two tracers (2). The method of Issekutz et al. (9) is also sensitive to measurement error (in other words, the noisier the data, the more variable the Ra estimate), and it gives the exact estimate of Ra only if the TTR of one of the two tracers is kept perfectly constant and the other is varying (2). Considering these results, we conclude that the approach of Issekutz et al. (9) is not preferable to the traditional fixed-volume single-pool model, since it does not guarantee a more precise estimate of Ra, and it is more costly and labor intensive, since it requires the simultaneous infusion of two tracers.

When all the data are considered together, it seems likely that under most circumstances the constant-infusion single-pool model is adequate to quantify glycerol kinetics, whereas the variable tracer infusion is preferable in the case of glucose. However, even in the case of glucose, a pool size of 145 ml/kg enables a reasonable estimation of Ra in a rapidly changing situation. The two-tracer approach does not provide sufficient improvement to justify the extra effort and expense and, in some cases, may even be less accurate than the single-tracer approach.


    APPENDIX
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
APPENDIX

With the model of Steele et al. (16), Ra can be estimated using the following equation
R<SUB>a</SUB>(<IT>t</IT>) = <FR><NU>i(<IT>t</IT>) − V(<IT>t</IT>) ⋅ C(<IT>t</IT>) ⋅ <FR><NU>dTTR(<IT>t</IT>)</NU><DE>d<IT>t</IT></DE></FR></NU><DE>TTR(<IT>t</IT>)</DE></FR> (A1)
where i(t) is the tracer infusion rate, TTR(t) is the tracer-to-tracee ratio, C(t) is the endogenous concentration, and V(t) is the volume of distribution. If only one tracer is infused, the value of V has to be assumed constant. If two tracers of the same substrate are infused, Ra can be estimated from the pattern of one of the two tracers as follows
R<SUB>a</SUB>(<IT>t</IT>) = <FR><NU>i<SUB>1</SUB>(<IT>t</IT>) − V(<IT>t</IT>) ⋅ C(<IT>t</IT>) ⋅ <FR><NU>dTTR<SUB>1</SUB>(<IT>t</IT>)</NU><DE>d<IT>t</IT></DE></FR></NU><DE>TTR<SUB>1</SUB>(<IT>t</IT>)</DE></FR> 

= <FR><NU>i<SUB>2</SUB>(<IT>t</IT>) − V(<IT>t</IT>) ⋅ C(<IT>t</IT>) ⋅ <FR><NU>dTTR<SUB>2</SUB>(<IT>t</IT>)</NU><DE>d<IT>t</IT></DE></FR></NU><DE>TTR<SUB>2</SUB>(<IT>t</IT>)</DE></FR> (A2)
From this equality we can derive V(t)
V(<IT>t</IT>) = <FR><NU>i<SUB>1</SUB>(<IT>t</IT>) − i<SUB>2</SUB>(<IT>t</IT>) ⋅ <IT>y</IT>(<IT>t</IT>)</NU><DE>C(<IT>t</IT>) ⋅ <FR><NU>d<IT>y</IT>(<IT>t</IT>)</NU><DE>d<IT>t</IT></DE></FR> ⋅ TTR<SUB>2</SUB>(<IT>t</IT>)</DE></FR> (A3)
where the new defined variable y(t) is
<IT>y</IT>(<IT>t</IT>) = <FR><NU>TTR<SUB>1</SUB>(<IT>t</IT>)</NU><DE>TTR<SUB>2</SUB>(<IT>t</IT>)</DE></FR> and <IT>z</IT>(<IT>t</IT>) = <FR><NU>TTR<SUB>2</SUB>(<IT>t</IT>)</NU><DE>TTR<SUB>1</SUB>(<IT>t</IT>)</DE></FR> (A4)
and
<FR><NU>d<IT>y</IT></NU><DE>d<IT>t</IT></DE></FR> = <FR><NU><FR><NU>d(TTR<SUB>1</SUB>)</NU><DE>d<IT>t</IT></DE></FR> ⋅ TTR<SUB>2</SUB> − <FR><NU>d(TTR<SUB>2</SUB>)</NU><DE>d<IT>t</IT></DE></FR> ⋅ TTR<SUB>1</SUB></NU><DE>(TTR<SUB>2</SUB>)<SUP>2</SUP></DE></FR> (A5)
The estimated value of V(t) can vary between zero and an infinite value. In fact, when the denominator of V(t) and, in particular, when the derivative of y(t) approach zero, V(t) tends to an infinite value. Considering the derivative of y(t), we can see that it equals zero when y(t) is constant, i.e., when the ratio of the two enrichments is constant or when
<FR><NU>d(TTR<SUB>1</SUB>)</NU><DE>d<IT>t</IT></DE></FR> ⋅ TTR<SUB>2</SUB> = <FR><NU>d(TTR<SUB>2</SUB>)</NU><DE>d<IT>t</IT></DE></FR> ⋅ TTR<SUB>1</SUB> (A6)
i.e., when both derivatives dTTR1/dt and dTTR2/dt approach zero. We have defined as tracer 1 the tracer that is infused at constant rate (which produces a variable TTR1). Tracer 2 is instead the tracer infused changing the rate to keep TTR2 constant. However, it appears clear from Eqs. A2-A4 that either tracer gives the same estimates of V(t) and Ra. Moreover, by substituting Eq. A3 or A4 into Eq. A1, the value of C(t) is cancelled out, and therefore C(t) is not necessary to calculate Ra by this approach
R<SUB>a</SUB>(<IT>t</IT>) = <FR><NU>i<SUB>1</SUB>(<IT>t</IT>) − <FR><NU>i<SUB>1</SUB>(<IT>t</IT>) − i<SUB>2</SUB>(<IT>t</IT>) ⋅ <IT>y</IT>(<IT>t</IT>)</NU><DE><FR><NU>d<IT>y</IT>(<IT>t</IT>)</NU><DE>d<IT>t</IT></DE></FR> ⋅ TTR<SUB>2</SUB>(<IT>t</IT>)</DE></FR> ⋅ <FR><NU>dTTR<SUB>1</SUB>(<IT>t</IT>)</NU><DE>d<IT>t</IT></DE></FR></NU><DE>TTR<SUB>1</SUB>(<IT>t</IT>)</DE></FR> (A7)
This can be an advantage when this approach is combined with stable isotope infusion, since the precision in the measurement of TTR is usually higher than that obtained in measuring concentration.


    ACKNOWLEDGEMENTS

The authors thank D. L. Chinkes, S. Klein, and J. I. Rosenblatt and the nurses and staff of the General Clinical Research Center at the University of Texas Medical Branch for their time and competent technical assistance.


    FOOTNOTES

This work was supported by Shriners Hospital Grant 8490. The General Clinical Research Center at the University of Texas Medical Branch is supported by National Institutes of Health Grant M01-0073.

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.

Address for reprint requests and other correspondence: R. R. Wolfe, Shriners Burns Institute, 815 Market St., Galveston, TX 77551.

Received 20 April 1998; accepted in final form 15 June 1999.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
APPENDIX

1.   Butler, P. C., A. Caumo, A. Zerman, P. C. O'Brien, C. Cobelli, and R. A. Rizza. Methods for assessment of the rate of onset and offset of insulin action during nonsteady state in humans. Am. J. Physiol. 264 (Endocrinol. Metab. 27): E548-E560, 1993[Abstract/Free Full Text].

2.   Caumo, A., A. Zerman, R. Rizza, and C. Cobelli. The dual tracer time-varying volume method for measuring hepatic glucose release in nonsteady state: theoretical and simulation results. Comput. Methods Programs Biomed. 41: 243-267, 1994[Medline].

3.   Cobelli, C., A. Mari, and E. Ferrannini. Non-steady state: error analysis of Steele's model and developments for glucose kinetics. Am. J. Physiol. 252 (Endocrinol. Metab. 15): E679-E689, 1987[Abstract/Free Full Text].

4.   Cobelli, C., G. Toffolo, D. M. Bier, and R. Nosadini. Models to interpret kinetic data in stable isotope tracer studies. Am. J. Physiol. 253 (Endocrinol. Metab. 16): E551-E564, 1987[Abstract/Free Full Text].

5.   Cobelli, C., G. Toffolo, and D. M. Foster. Tracer-to-tracee ratio for analysis of stable isotope tracer data: link with radioactive kinetic formalism. Am. J. Physiol. 262 (Endocrinol. Metab. 25): E968-E975, 1992[Abstract/Free Full Text].

6.   Coggan, A. R. Plasma glucose metabolism during exercise in humans. Sports Med. 11: 102-124, 1991[Medline].

7.   Finegood, D. T., R. N. Bergman, and M. Vranic. Modelling error and apparent isotope discrimination confound estimation of endogenous glucose production during euglycemic glucose clamp. Diabetes 37: 1025-1034, 1988[Abstract].

8.   Finegood, D. T., P. D. G. Miles, H. L. A. Lickley, and M. Vranic. Estimation of glucose production during exercise with a one-compartment variable-volume model. J. Appl. Physiol. 72: 2501-2509, 1992[Abstract/Free Full Text].

9.   Issekutz, T., R. Issekutz, and D. Elahi. Estimation of hepatic glucose output in non-steady state. The simultaneous use of 2-3H-glucose and 14C-glucose in the dog. Can. J. Physiol. Pharmacol. 52: 215-224, 1974[Medline].

10.   Matthews, D. E., G. R. Pesola, and V. Kvetan. Glycerol metabolism in humans: validation of 2H- and 13C-labelled tracers. Acta Diabetol. 28: 179-184, 1991[Medline].

11.   Molina, J. M., A. D. Baron, S. V. Edelman, G. Brechtel, P. Wallace, and J. M. Olefsky. Use of a variable tracer infusion method to determine glucose turnover in humans. Am. J. Physiol. 258 (Endocrinol. Metab. 21): E16-E23, 1990[Abstract/Free Full Text].

12.   Radziuk, J., K. H. Norwich, and M. Vranic. Experimental validation of measurements of glucose turnover in nonsteady state. Am. J. Physiol. 234 (Endocrinol. Metab. Gastrointest. Physiol. 3): E84-E93, 1978[Abstract/Free Full Text].

13.   Romijn, J. A., E. F. Coyle, L. S. Sidossis, A. Gastaldelli, J. F. Horowitz, E. Endert, and R. R. Wolfe. Regulation of endogenous fat and carbohydrate metabolism in relation to exercise intensity and duration. Am. J. Physiol. 265 (Endocrinol. Metab. 28): E380-E391, 1993[Abstract/Free Full Text].

14.   Rosenblatt, J. I., D. L. Chinkes, M. Wolfe, and R. R. Wolfe. Stable isotope tracer analysis by GC-MS, including quantification of isotopomer effects. Am. J. Physiol. 263 (Endocrinol. Metab. 26): E584-E596, 1992[Abstract/Free Full Text].

15.   Saccá, L. Role of counterregulatory hormones in the regulation of hepatic glucose metabolism. Diabetes Metab. Rev. 3: 207-229, 1987[Medline].

16.   Steele, R. W., J. S. Wall, R. C. DeBodo, and N. Altszuler. Measurement of size and turnover rate of body glucose pool by the isotope dilution method. Am. J. Physiol. 187: 15-24, 1956.

17.   Wolfe, R. R. Radioactive and Stable Isotope Tracers in Biomedicine. New York: Wiley-Liss, 1992.


J APPL PHYSIOL 87(5):1813-1822
8570-7587/99 $5.00 Copyright © 1999 the American Physiological Society



This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
T. J. Horton, S. Dow, M. Armstrong, and W. T. Donahoo
Greater systemic lipolysis in women compared with men during moderate-dose infusion of epinephrine and/or norepinephrine
J Appl Physiol, July 1, 2009; 107(1): 200 - 210.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. Gastaldelli, A. Casolaro, D. Ciociaro, S. Frascerra, M. Nannipieri, E. Buzzigoli, and E. Ferrannini
Decreased whole body lipolysis as a mechanism of the lipid-lowering effect of pioglitazone in type 2 diabetic patients
Am J Physiol Endocrinol Metab, July 1, 2009; 297(1): E225 - E230.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
R. Antonione, E. Caliandro, F. Zorat, G. Guarnieri, M. Heer, and G. Biolo
Whey Protein Ingestion Enhances Postprandial Anabolism during Short-Term Bed Rest in Young Men
J. Nutr., November 1, 2008; 138(11): 2212 - 2216.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
R. Roberts, A. S Bickerton, B. A Fielding, E. E Blaak, A. J Wagenmakers, M. F-F Chong, M. Gilbert, F. Karpe, and K. N Frayn
Reduced oxidation of dietary fat after a short term high-carbohydrate diet
Am. J. Clinical Nutrition, April 1, 2008; 87(4): 824 - 831.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M. C. G. van de Poll, S. J. Wigmore, D. N. Redhead, R. G. H. Beets-Tan, O. J. Garden, J. W. M. Greve, P. B. Soeters, N. E. P. Deutz, K. C. H. Fearon, and C. H. C. Dejong
Effect of major liver resection on hepatic ureagenesis in humans
Am J Physiol Gastrointest Liver Physiol, November 1, 2007; 293(5): G956 - G962.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
R. Andrew, J. Westerbacka, J. Wahren, H. Yki-Jarvinen, and B. R. Walker
The Contribution of Visceral Adipose Tissue to Splanchnic Cortisol Production in Healthy Humans
Diabetes, May 1, 2005; 54(5): 1364 - 1370.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
B. Mittendorfer, D. A. Fields, and S. Klein
Excess body fat in men decreases plasma fatty acid availability and oxidation during endurance exercise
Am J Physiol Endocrinol Metab, March 1, 2004; 286(3): E354 - E362.
[Abstract] [Full Text]


Home page
J. Appl. Physiol.Home page
C. Y. Christ-Roberts, T. Pratipanawatr, W. Pratipanawatr, R. Berria, R. Belfort, and L. J. Mandarino
Increased insulin receptor signaling and glycogen synthase activity contribute to the synergistic effect of exercise on insulin action
J Appl Physiol, December 1, 2003; 95(6): 2519 - 2529.
[Abstract] [Full Text]


Home page
DiabetesHome page
B. Mittendorfer, O. Liem, B. W. Patterson, J. M. Miles, and S. Klein
What Does the Measurement of Whole-Body Fatty Acid Rate of Appearance in Plasma by Using a Fatty Acid Tracer Really Mean?
Diabetes, July 1, 2003; 52(7): 1641 - 1648.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. M Buijs, J. Burggraaf, C. Wijbrandts, M. L de Kam, M. Frolich, A. F Cohen, J. A Romijn, H. P Sauerwein, A E. Meinders, and H. Pijl
Blunted lipolytic response to fasting in abdominally obese women: evidence for involvement of hyposomatotropism
Am. J. Clinical Nutrition, March 1, 2003; 77(3): 544 - 550.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. M. Buijs, J. Burggraaf, J. G. Langendonk, R. C. Schoemaker, M. Frolich, J.-W. Arndt, A. F. Cohen, J. A. Romijn, M. T. Ackermans, H. P. Sauerwein, et al.
Hyposomatotropism Blunts Lipolysis in Abdominally Obese Women
J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3851 - 3858.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
B. Mittendorfer, J. F. Horowitz, and S. Klein
Effect of gender on lipid kinetics during endurance exercise of moderate intensity in untrained subjects
Am J Physiol Endocrinol Metab, July 1, 2002; 283(1): E58 - E65.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gastaldelli, A.
Right arrow Articles by Wolfe, R. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gastaldelli, A.
Right arrow Articles by Wolfe, R. R.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online